<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03728608</url>
  </required_header>
  <id_info>
    <org_study_id>IRB201700398 -N-A</org_study_id>
    <secondary_id>R01NR016964-01A1</secondary_id>
    <nct_id>NCT03728608</nct_id>
  </id_info>
  <brief_title>Optimal Feeding Tube Dwell Time in VLBW Infants to Reduce Feeding Tube Contamination</brief_title>
  <official_title>Optimal Feeding Tube Dwell Time in VLBW Infants to Reduce Feeding Tube Contamination</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Nursing Research (NINR)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Florida</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study team will determine whether a decreased feeding tube dwell time will reduce feeding
      tube contamination
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Contaminated feeding tubes can occur in the neonatal intensive care unit (NICU) and have been
      associated with significant morbidity. Due to an immature immunologic systems, premature
      infants are at significant risk of complications related to contaminated feeding tubes.
      Feeding tube dwell time may affect the level of contamination. This study will determine if a
      maximum feeding tube dwell time of 48 hours reduces contamination compared to a maximum
      feeding tube dwell time of 7 days, thereby improving neonatal health outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 10, 2017</start_date>
  <completion_date type="Anticipated">May 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Amount of contamination</measure>
    <time_frame>24 hours</time_frame>
    <description>prepared solution of sectioned feeding tubes will be plated on Agar. After 24 hrs of incubation, unique colony types will be counted.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse Event rate</measure>
    <time_frame>up to 20 weeks</time_frame>
    <description>The adverse events will be recorded and monitored during the NICU stay relating to sepsis, pneumonia and feeding intolerance, and necrotizing enterocolitis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gastrointestinal inflammation - Bio Rad</measure>
    <time_frame>up to 20 weeks</time_frame>
    <description>The samples will be analyzed for inflammatory markers using BioRad Bio-Plex platform</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gastrointestinal inflammation - S100A12</measure>
    <time_frame>up to 20 weeks</time_frame>
    <description>The samples will be analyzed for inflammatory markers using S100A12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gastrointestinal inflammation - calprotectin</measure>
    <time_frame>up to 20 weeks</time_frame>
    <description>The samples will be analyzed for inflammatory markers using calprotectin immunoassays</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">268</enrollment>
  <condition>Infection</condition>
  <arm_group>
    <arm_group_label>Group 1--Short Dwell</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Premature VLBW (very low birth weight) male and female infants will be randomly assigned to have their feeding tubes removed at 0-48 hours for the first 4 weeks of life.The feeding tube lumen, interluminal liquid and hub will be analyzed for level of contamination.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2--Long Dwell</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Premature VLBW (very low birth weight) male and female infants will be randomly assigned to have their feeding tubes removed at 7 days for the first 4 weeks of life.The feeding tube lumen, interluminal liquid and hub will be analyzed for level of contamination.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Feeding tube dwell time of 48 hours</intervention_name>
    <description>Feeding tube dwell time of 48 hours for first 4 weeks of life.</description>
    <arm_group_label>Group 1--Short Dwell</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Feeding tube dwell time of 7 day</intervention_name>
    <description>Feeding tube dwell time of 7 days for first 4 weeks of life.</description>
    <arm_group_label>Group 2--Long Dwell</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  be born to a mother who is at least 18 years of age and English-speaking

          -  born at &lt; 30 weeks 3) have a birthweight &lt; 1500 grams

          -  have a feeding tube placed within 12 hours of birth

          -  be expected to require a feeding tube for 4 weeks following birth.

        Exclusion Criteria:

          -  infant with known GI anomalies

          -  infants which are not expected to live

          -  infants will be withdrawn from the study if they require abdominal surgery for GI
             morbidities
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Weeks</minimum_age>
    <maximum_age>40 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leslie Parker</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Leslie Parker</last_name>
    <phone>352-273-6636</phone>
    <email>parkela@ufl.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shannon Perry</last_name>
    <phone>352-273-6636</phone>
    <email>perrysg66@ufl.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Unversity of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>October 24, 2018</study_first_submitted>
  <study_first_submitted_qc>October 30, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 2, 2018</study_first_posted>
  <last_update_submitted>March 10, 2020</last_update_submitted>
  <last_update_submitted_qc>March 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>neonatal intensive care unit (NICU)</keyword>
  <keyword>feeding tube contamination</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

